Evidence map›Paper›PMID 31870113›Full record

ArticleAsian Pacific journal of cancer prevention : APJCP2019

Delays in Diagnosis and Treatment of Breast Cancer and the Pathways of Care: A Mixed Methods Study from a Tertiary Cancer Centre in North East India.

Arvind Kumar, Srabana Misra Bhagabaty, Jaya Prasad Tripathy, Kalaiselvi Selvaraj, Joydeep Purkayastha, Ravikant Singh

Open access · goldAbstract read
In one paragraph

Article in Asian Pacific journal of cancer prevention : APJCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 9 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 9 pooled it
2.2field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 9 syntheses or guidelines pooled it, 74 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Article
  11. Article
  12. Article
  13. Barriers to help-seeking for cancer in India: A scoping review.The Indian journal of medical research · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Arvind KumarPublic Health, Cluster Coordinator, Doctors For You, Guwahati, India.ORCID 0000-0001-7600-6415
Srabana Misra BhagabatyDepartment of Preventive Oncology, Dr. B. Borooah Cancer Institute, Guwahati, India.
Jaya Prasad TripathyDepartment of Community Medicine, Assistant Professor, All India Institute of Medical Sciences, Nagpur, India.
Kalaiselvi SelvarajDepartment of Community Medicine, Assistant Professor, All India Institute of Medical Sciences, Nagpur, India.
Joydeep PurkayasthaDepartment of Preventive Oncology, Dr. B. Borooah Cancer Institute, Guwahati, India.
Ravikant SinghPublic Health, Cluster Coordinator, Doctors For You, Guwahati, India.
All India Institute of Medical Sciences, Nagpur · INBhubaneswar Borooah Cancer Institute · INDoctors Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionIn India, mortality rate in breast cancer is high because more than half are diagnosed late at locally advanced or metastatic stages. This might be due to presentation delay (recognition of symptoms to first provider consultation) and treatment delay (first provider consultation to initiation of treatment), together known as overall delay. We aimed to estimate the overall delay in diagnosis and treatment in breast cancer and the associated factors, describe pathway of care and explore the reasons for delay from a patients' and providers' perspective.

methodsExplanatory sequential mixed-methods study with a quantitative component (retrospective cohort study including breast cancer patients registered at Dr. Borooah Cancer Institute (BBCI), Guwahati during February-June 2019) followed by descriptive qualitative component (in-depth interviews with 15 patients and 10 care providers).

resultsOf 269 breast cancer patients, median (Inter Quartile Range) overall delay was 203 (110-401) days, presentation delay was 35 (10-112) days and treatment delay was 130 (75-258) days. Majority of patients approached private sector (190, 70.6%) as the first care provider. Nearly half of all patients (136, 50.6%) visited one health care provider before reaching the BBCI and another one-third (90, 33.5%) visited two providers. Reasons for presentation delay were misconception about the disease, perceived stigma, fear and denial of cancer, attribution of symptoms to trivial conditions, family responsibilities and embarrassment of breast examination by a male doctor. Treatment delay was due to initial visit to, misclassification of disease severity, dissatisfaction with care at public facilities, poor accessibility and affordability, fear of treatment and its side effects.

conclusionTreatment delay was the major contributor to overall delay. Private providers need to be sensitized and trained in screening of breast cancer and referral of suspected cases of cancer. More awareness is needed about warning symptoms of breast cancer and misconceptions regarding the disease.<br />.

Indexed as

Delayed DiagnosisHealth Knowledge, Attitudes, PracticeTime-to-TreatmentAdultAgedBreast NeoplasmsFemaleFollow-Up StudiesHealth PersonnelHumansIndiaMiddle AgedPatient Acceptance of Health CarePrognosisQualitative ResearchRetrospective Studiesbreast cancerdelayMixed methodNorth East India

Identifiers

PMID31870113
PMCPMC7173377
OpenAlexW2990566548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.